Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold

Core Insights - Invivyd, Inc. has formed a strategic partnership with football coach Jim Harbaugh to raise awareness about the ongoing risks of COVID-19, particularly for immunocompromised individuals [1][3][7] - Despite the availability of vaccines and therapies, COVID-19 continues to pose significant health risks, with approximately 59,000 deaths and 665,000 hospitalizations reported in 2024 [2][7] - The long-term impacts of COVID-19 may exceed those of several chronic diseases, creating a substantial burden on healthcare systems and society [2][10] Company Overview - Invivyd, Inc. is a biopharmaceutical company focused on providing protection against serious viral infectious diseases, starting with SARS-CoV-2 [4] - The company utilizes a proprietary technology platform to develop and adapt antibodies, having received emergency use authorization for a monoclonal antibody in March 2024 [4] Health Impact and Statistics - COVID-19 is causing an American death approximately every 9 minutes, highlighting the ongoing severity of the pandemic [2][7] - The percentage of COVID-19 hospitalizations requiring intensive care unit (ICU) admissions is increasing again, indicating a rising health crisis [2] - The 2023-2024 respiratory season saw hospitalizations calculated based on a U.S. population estimate of 334.9 million [6][9]